According to GlobalData epidemiologists, the US had the highest number of diagnosed prevalent cases of T1D in 2023 with 1.77 million in 2023, whereas Japan had the lowest number of prevalent cases at 120,000.
Meanwhile, CM Sarma, who is also the BJP co-in-charge for Jharkhand elections, returned to Assam after carrying out the election campaign and posted on X, "Over the past four months, Jharkhand has truly felt like a second home to me. While I may have made a few adversaries during this period, they are far outnumbered by the friendships I've forged across this vibrant state."
He said that the unit will function under the department of neurosurgery and the department of ear, nose, and throat (ENT). It will be led by consultant ENT surgeon at Bombay Hospital, Nishit Shah, and H N Reliance Mumbai, alongside head of the neurosurgery department at GMC, Ponraj Sundaram.
The Ireland-based company raised the lower end of its 2025 adjusted profit forecast to $5.44 per share from $5.42 earlier, keeping the upper end at $5.50. The new midpoint of $5.47 is slightly higher than analysts' estimates of $5.45, according to data compiled by LSEG.
ARI is projected to report over two million scans annually, spanning 24 countries and serving more than 200 healthcare organizations. Through this acquisition, ARI aims to expand its reporting services across a broader network of NHS partners in the UK.
However, many people are using surgical masks, made ubiquitous by the Covid pandemic, because it is very affordable though they aren't effective in shielding people against respirable pollutants. Opposite AIIMS at Safdarjung Medicos, shopkeeper Javed said. "People are opting for cheaper surgical masks. We don't recommend its use, but it is cheaper," the shopkeeper said.
Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both communicable and non-communicable diseases. The integration of AI, machine learning, and affordable diagnostic platforms will play a key role in democratizing healthcare, ensuring access to high-quality diagnostic services even in Tier 3 cities. Collaborations with private and government insurance schemes, like Ayushman Bharat, will further propel this transformation, making genomic screening a part of primary healthcare.
AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS vessel images during percutaneous coronary intervention (PCI) procedures.
Dr Nandi was invited to Delhi to attend the annual Health Research Excellence Summit hosted by ICMR, where he was also recognised for his pioneering use of gene-editing technology to enhance polio safety protocols in research labs nationwide.
The ZEMBA tender aims to aggregate over 80 billion tonne-nautical miles of demand for zero-emission shipping and is set to introduce e-fuel-powered container shipping at scale by 2027.
The investment will accelerate OptraSCAN’s development of cutting-edge diagnostic testing equipment. “The strategic alliance with OptraSCAN is a significant step in our mission to make healthcare diagnostic devices accessible in India and beyond,” said Sriram Natarajan, chief executive officer of Molbio Diagnostics.
The proposed manufacturing facility will be operational by 2026 and will increase Lubrizol’s local medical tubing volume five-fold.These tubes will be used in neurovascular and cardiovascular medical applications, such as balloon catheters and minimally invasive procedure catheters.
Myopia Master uses a contactless, painless approach to measure critical eye parameters such as axial length, keratometry, and refraction, allowing for accurate monitoring and personalised treatment plans. By measuring key parameters of eye health and utilising a unique AI-based model for data analysis, it ensures personalised, effective care for every child, setting a new standard in myopia management.
Robotic surgery, with its advantages over conventional open and laparoscopic surgeries—such as faster recovery times, reduced blood loss, lower infection risks, shorter hospital stays, and the ability to perform highly complex procedures—is fast becoming essential.
In addition to improved access to diagnostic tools, this collaboration will support AI-driven pathology solutions that aim to empower healthcare professionals to diagnose diseases more efficiently, leading to better patient outcomes. With this partnership, OptraSCAN can expand its product portfolio and increase availability, making life-saving diagnostic technology accessible to facilities in rural and under-resourced regions in India.
Alcon, whose biggest market is the U.S. making up nearly a half of its revenue, said it expected annual net sales to grow by 6-7% in constant currency terms, compared to the previous forecast of 7-9%.
Unusually precise measurements of cardiac troponin I made possible using the Mindray assay, meant additional individuals could also be ruled out. In total, across all cardiac troponin I measures, researchers were able to identify 60 per cent of patients presenting to the emergency department with heart attack like symptoms, who could be safely sent home.
The new Azurion system brings state of the art imaging capabilities and flexible ergonomic gantry positioning to optimise clinician workflow, ensuring faster and more precise treatment for the patients. By allowing interventionalists to treat more patients, more efficiently, with potentially better outcomes, Azurion enhances both the staff and patient experience and contributes to lower cost of care.
Diabetes is a silent killer—early detection is the only way to win the battle.Taking control of your sugar today means fewer complications tomorrow.A healthy lifestyle is the sweetest gift you can give yourself and your family.Each one of us has the power to prevent diabetes from taking over our lives or loved ones'.
Pursuant to an earlier orders, state health secretary filed a status report before the court explaining the steps taken to fill up vacancies of dialysis technicians. The report stated that there are 768 dialysis machines across the state, of which 688 are in working condition and 10% of machines are under service.
Photodetectors, essential devices in modern technology, detect light and convert it into electrical signals. They are integral to various applications, including cameras, medical imaging equipment, environmental sensors, and communication systems. Despite their importance, achieving high-performance photodetectors at a low production cost has long been a challenge. The team at IIT Guwahati has made a significant breakthrough in addressing this challenge.
India's medical device industry is celebrating a new ₹500 crore government scheme designed to boost domestic manufacturing and reduce reliance on imports. The scheme will fund key initiatives such as manufacturing essential components, developing shared infrastructure, and supporting clinical studies, ultimately aiming to position India as a global leader in medical technology.
The session delved into recent insights in interpreting laboratory results with a focus on routine tests that help improve accuracy, efficiency, and patient outcomes. Attendees benefited from insights into how newer concepts in interpretation have improved lab diagnostics and have helped in supporting early detection and prevention of diseases.
Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand for non-essential surgical procedures, especially among older patients. On an adjusted basis, New Jersey-based Becton expects to earn between $14.25 and $14.60 per share in fiscal year 2025, the mid-point of which is above analysts' estimate of $14.34, according to data compiled by LSEG.
It is one of the common alternatives chosen by couples to conceive, especially in cases of blocked fallopian tubes in females, male factor infertility, recurrent miscarriages, endometriosis, or diminished ovarian reserve. During this procedure, the eggs and sperms are combined outside the body in a controlled laboratory environment, and the resulting embryo is transferred back into the uterus with the aim of fulfilling the dream of having a baby.
Minnesota-based Solventum is one of the largest providers of sterilization devices, wound dressings, medical tape and other hospital consumables used by healthcare facilities.
Prof Pranjal Chandra from the School of Biochemical Engineering, who, along with a PhD student Divya, led the team. Chandra said that CKD emerged as a global health crisis, affecting over 800 million people worldwide, or more than 10% of the global population.
The Columbus, Ohio-based company reported third-quarter revenue of $954.54 million, beating estimates of $944.74 million, as per data compiled by LSEG. Lifesciences firms, including Mettler-Toledo, have seen sluggish demand for their instruments used in drug development due to decreased spending in the biotech sector and weak demand from China, a key region for drug development.
Brand Connect Initiative
The company now expects its annual 2024 revenue to grow between 20% and 21%, up from its previous forecast of 16% to 19% growth, driven by strong sales of its Omnipod devices.
Dr Olale's leadership at MedGenome will accelerate the company’s transformation into the preferred partner for academic institutions, biopharma, and biotech companies seeking advanced multiomic and genomic technologies to tackle the most challenging scientific questions, helping them develop medicines for patients in areas of unmet need. Rose brings extensive expertise in lifesciences, having previously served as Regional Vice President of Business Development at Precision for Medicine, a global clinical research organisation.
The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the inside of the heart to help break up the electrical signals that cause irregular heartbeats.
With MicrobioTx’s Gut Function Test (GFT), gut microbiome profiling, which was earlier only possible by stool sample, will now be possible with a finger-prick without the need of collecting a stool sample.
The Dublin-based company reiterated its adjusted profit forecast for fiscal 2025 of $9.05 per share to $9.25 per share. Analysts expect a profit of $9.16 apiece for the year.
The company also said it is reaffirming its 2024 sales forecast of at least $1.99 billion CER, "based on the solid core business performance in the first nine months of the year."
Deep Brain Stimulation (DBS) involves implanting electrodes in specific areas of the brain that deliver electrical pulses to help regulate abnormal brain activity. This can alleviate symptoms such as tremors, stiffness, slowness, and involuntary movements. A small neurostimulator device is also placed under the skin, usually in the chest area, to power the electrodes.
During these operations, surgeons traditionally try to put the hip, knee and ankle in a straight line. This study, published in The Bone and Joint Journal, found that to be a bad idea if those parts of the body were not in a straight line to begin with.
The device, created by Imaginarium, a multi-specialty digital manufacturing company, was specifically tailored for Anamta, helping her navigate the challenges of a complex recovery post-transplant. “Knowing I’m the first transplant patient with a custom 3D-printed brace is exciting,” she shared.
GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns about overdiagnosis, exposure of sensitive health data, and the potential for insurers to adjust premiums based on test outcomes.
Fresenius reported third-quarter revenue of 5.30 billion euros ($5.69 billion) and EBIT before special items of 522 million euros, beating a company-provided consensus by 1.7% and 3.4% respectively.
According to GlobalData epidemiologists, the US had the highest number of diagnosed prevalent cases of T1D in 2023 with 1.77 million in 2023, whereas Japan had the lowest number of prevalent cases at 120,000.
Meanwhile, CM Sarma, who is also the BJP co-in-charge for Jharkhand elections, returned to Assam after carrying out the election campaign and posted on X, "Over the past four months, Jharkhand has truly felt like a second home to me. While I may have made a few adversaries during this period, they are far outnumbered by the friendships I've forged across this vibrant state."
He said that the unit will function under the department of neurosurgery and the department of ear, nose, and throat (ENT). It will be led by consultant ENT surgeon at Bombay Hospital, Nishit Shah, and H N Reliance Mumbai, alongside head of the neurosurgery department at GMC, Ponraj Sundaram.
The Ireland-based company raised the lower end of its 2025 adjusted profit forecast to $5.44 per share from $5.42 earlier, keeping the upper end at $5.50. The new midpoint of $5.47 is slightly higher than analysts' estimates of $5.45, according to data compiled by LSEG.
ARI is projected to report over two million scans annually, spanning 24 countries and serving more than 200 healthcare organizations. Through this acquisition, ARI aims to expand its reporting services across a broader network of NHS partners in the UK.
However, many people are using surgical masks, made ubiquitous by the Covid pandemic, because it is very affordable though they aren't effective in shielding people against respirable pollutants. Opposite AIIMS at Safdarjung Medicos, shopkeeper Javed said. "People are opting for cheaper surgical masks. We don't recommend its use, but it is cheaper," the shopkeeper said.
Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both communicable and non-communicable diseases. The integration of AI, machine learning, and affordable diagnostic platforms will play a key role in democratizing healthcare, ensuring access to high-quality diagnostic services even in Tier 3 cities. Collaborations with private and government insurance schemes, like Ayushman Bharat, will further propel this transformation, making genomic screening a part of primary healthcare.
AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS vessel images during percutaneous coronary intervention (PCI) procedures.
Dr Nandi was invited to Delhi to attend the annual Health Research Excellence Summit hosted by ICMR, where he was also recognised for his pioneering use of gene-editing technology to enhance polio safety protocols in research labs nationwide.
The ZEMBA tender aims to aggregate over 80 billion tonne-nautical miles of demand for zero-emission shipping and is set to introduce e-fuel-powered container shipping at scale by 2027.
The investment will accelerate OptraSCAN’s development of cutting-edge diagnostic testing equipment. “The strategic alliance with OptraSCAN is a significant step in our mission to make healthcare diagnostic devices accessible in India and beyond,” said Sriram Natarajan, chief executive officer of Molbio Diagnostics.
The proposed manufacturing facility will be operational by 2026 and will increase Lubrizol’s local medical tubing volume five-fold.These tubes will be used in neurovascular and cardiovascular medical applications, such as balloon catheters and minimally invasive procedure catheters.
Myopia Master uses a contactless, painless approach to measure critical eye parameters such as axial length, keratometry, and refraction, allowing for accurate monitoring and personalised treatment plans. By measuring key parameters of eye health and utilising a unique AI-based model for data analysis, it ensures personalised, effective care for every child, setting a new standard in myopia management.
Robotic surgery, with its advantages over conventional open and laparoscopic surgeries—such as faster recovery times, reduced blood loss, lower infection risks, shorter hospital stays, and the ability to perform highly complex procedures—is fast becoming essential.
In addition to improved access to diagnostic tools, this collaboration will support AI-driven pathology solutions that aim to empower healthcare professionals to diagnose diseases more efficiently, leading to better patient outcomes. With this partnership, OptraSCAN can expand its product portfolio and increase availability, making life-saving diagnostic technology accessible to facilities in rural and under-resourced regions in India.
Alcon, whose biggest market is the U.S. making up nearly a half of its revenue, said it expected annual net sales to grow by 6-7% in constant currency terms, compared to the previous forecast of 7-9%.
Unusually precise measurements of cardiac troponin I made possible using the Mindray assay, meant additional individuals could also be ruled out. In total, across all cardiac troponin I measures, researchers were able to identify 60 per cent of patients presenting to the emergency department with heart attack like symptoms, who could be safely sent home.
The new Azurion system brings state of the art imaging capabilities and flexible ergonomic gantry positioning to optimise clinician workflow, ensuring faster and more precise treatment for the patients. By allowing interventionalists to treat more patients, more efficiently, with potentially better outcomes, Azurion enhances both the staff and patient experience and contributes to lower cost of care.
Diabetes is a silent killer—early detection is the only way to win the battle.Taking control of your sugar today means fewer complications tomorrow.A healthy lifestyle is the sweetest gift you can give yourself and your family.Each one of us has the power to prevent diabetes from taking over our lives or loved ones'.
Pursuant to an earlier orders, state health secretary filed a status report before the court explaining the steps taken to fill up vacancies of dialysis technicians. The report stated that there are 768 dialysis machines across the state, of which 688 are in working condition and 10% of machines are under service.
Photodetectors, essential devices in modern technology, detect light and convert it into electrical signals. They are integral to various applications, including cameras, medical imaging equipment, environmental sensors, and communication systems. Despite their importance, achieving high-performance photodetectors at a low production cost has long been a challenge. The team at IIT Guwahati has made a significant breakthrough in addressing this challenge.
India's medical device industry is celebrating a new ₹500 crore government scheme designed to boost domestic manufacturing and reduce reliance on imports. The scheme will fund key initiatives such as manufacturing essential components, developing shared infrastructure, and supporting clinical studies, ultimately aiming to position India as a global leader in medical technology.
The session delved into recent insights in interpreting laboratory results with a focus on routine tests that help improve accuracy, efficiency, and patient outcomes. Attendees benefited from insights into how newer concepts in interpretation have improved lab diagnostics and have helped in supporting early detection and prevention of diseases.
Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand for non-essential surgical procedures, especially among older patients. On an adjusted basis, New Jersey-based Becton expects to earn between $14.25 and $14.60 per share in fiscal year 2025, the mid-point of which is above analysts' estimate of $14.34, according to data compiled by LSEG.
It is one of the common alternatives chosen by couples to conceive, especially in cases of blocked fallopian tubes in females, male factor infertility, recurrent miscarriages, endometriosis, or diminished ovarian reserve. During this procedure, the eggs and sperms are combined outside the body in a controlled laboratory environment, and the resulting embryo is transferred back into the uterus with the aim of fulfilling the dream of having a baby.
Minnesota-based Solventum is one of the largest providers of sterilization devices, wound dressings, medical tape and other hospital consumables used by healthcare facilities.
Prof Pranjal Chandra from the School of Biochemical Engineering, who, along with a PhD student Divya, led the team. Chandra said that CKD emerged as a global health crisis, affecting over 800 million people worldwide, or more than 10% of the global population.
The Columbus, Ohio-based company reported third-quarter revenue of $954.54 million, beating estimates of $944.74 million, as per data compiled by LSEG. Lifesciences firms, including Mettler-Toledo, have seen sluggish demand for their instruments used in drug development due to decreased spending in the biotech sector and weak demand from China, a key region for drug development.
Brand Connect Initiative
The company now expects its annual 2024 revenue to grow between 20% and 21%, up from its previous forecast of 16% to 19% growth, driven by strong sales of its Omnipod devices.
Dr Olale's leadership at MedGenome will accelerate the company’s transformation into the preferred partner for academic institutions, biopharma, and biotech companies seeking advanced multiomic and genomic technologies to tackle the most challenging scientific questions, helping them develop medicines for patients in areas of unmet need. Rose brings extensive expertise in lifesciences, having previously served as Regional Vice President of Business Development at Precision for Medicine, a global clinical research organisation.
The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the inside of the heart to help break up the electrical signals that cause irregular heartbeats.
With MicrobioTx’s Gut Function Test (GFT), gut microbiome profiling, which was earlier only possible by stool sample, will now be possible with a finger-prick without the need of collecting a stool sample.
The Dublin-based company reiterated its adjusted profit forecast for fiscal 2025 of $9.05 per share to $9.25 per share. Analysts expect a profit of $9.16 apiece for the year.
The company also said it is reaffirming its 2024 sales forecast of at least $1.99 billion CER, "based on the solid core business performance in the first nine months of the year."
Deep Brain Stimulation (DBS) involves implanting electrodes in specific areas of the brain that deliver electrical pulses to help regulate abnormal brain activity. This can alleviate symptoms such as tremors, stiffness, slowness, and involuntary movements. A small neurostimulator device is also placed under the skin, usually in the chest area, to power the electrodes.
During these operations, surgeons traditionally try to put the hip, knee and ankle in a straight line. This study, published in The Bone and Joint Journal, found that to be a bad idea if those parts of the body were not in a straight line to begin with.
The device, created by Imaginarium, a multi-specialty digital manufacturing company, was specifically tailored for Anamta, helping her navigate the challenges of a complex recovery post-transplant. “Knowing I’m the first transplant patient with a custom 3D-printed brace is exciting,” she shared.
GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns about overdiagnosis, exposure of sensitive health data, and the potential for insurers to adjust premiums based on test outcomes.
Fresenius reported third-quarter revenue of 5.30 billion euros ($5.69 billion) and EBIT before special items of 522 million euros, beating a company-provided consensus by 1.7% and 3.4% respectively.